1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, October 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, October 2016 (p7)

181-210 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Superoxide Dismutase ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States, World
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycogen Synthase Kinase ...

  • Industries : Chronic Disease, Pathology, Biopharmaceutical, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States, Asia
Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION The ubiquitin proteasome system (UPS) is one of the key protein degradation pathway involved in the control of protein homeostasis and turnover that mediates the regulation of several cellula ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile ...

  • Countries : United States
Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic ...

  • Industries : Therapy, Oncology, Cancer
  • Countries : United States
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Pathology
  • Countries : World, Europe, United States
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) ...

  • Industries : Mental Health, Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Gastroenteritis - Pipeline Review, H2 2016

Gastroenteritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States
Hepatitis D - Pipeline Review, H2 2016

Hepatitis D - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Pathology
  • Countries : United States
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Biological Therapy, Pathology, Healthcare, Biotechnology, Therapy
  • Countries : United States
Humira Biosimilars Clinical Trial Insight

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States
C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C ...

  • Industries : Biological Therapy, Pathology, Chronic Disease, Biotechnology
  • Countries : United States
Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016 Summary ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology
  • Countries : World, United States, Japan, Israel
Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Eukaryotic Translation Initiation ...

  • Industries : Cancer, Biopharmaceutical, Therapy, Pathology, Drug Discovery and Development
  • Countries : World, United States
Hemophilia B - Pipeline Review, H2 2016

Hemophilia B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hemophilia B - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology
  • Countries : United States, World, Europe
Hepatitis C - Pipeline Review, H2 2016

Hepatitis C - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : Europe, United States, World
Neutropenia - Pipeline Review, H2 2016

Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H2 2016’, provides an overview of the Neutropenia pipeline landscape. The report provides comprehensive ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biological Therapy, Biotechnology, Therapy
  • Countries : United States
Hypersensitivity - Pipeline Review, H2 2016

Hypersensitivity - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hypersensitivity - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape. The report ...

  • Industries : Pharmaceutical, Therapy, Pathology, OTC
  • Countries : United States, World, Japan
Myocardial Infarction - Pipeline Review, H2 2016

Myocardial Infarction - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2016’, provides an overview of the Myocardial Infarction pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Psoriasis - Pipeline Review, H2 2016

Psoriasis - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • September 2016
  • by Global Markets Direct

Psoriasis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) - Pipeline Review, H2 2016

Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States, World
Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016

Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : OTC, Pharmaceutical
  • Countries : United States
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pipeline Review, H2 2016

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myc Proto Oncogene Protein (Transcription ...

  • Industries : Therapy, Cancer, Health Facility, Pathology, Biopharmaceutical
  • Countries : United States, World

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.